ZS Pharma

Committed to Advancing Patient Care

  • Developing New Therapies to Improve the Treatment of HyperkalemiaThe core of our R&D program is to develop safe and efficacious treatments for patients with serious conditions using a novel selective ion-trap technology
  • Partnering with Clinicians to Advance Hyperkalemia Treatment ZS Pharma is committed to improving patient outcomes by developing novel therapies to treat potentially life-threatening conditions, such as hyperkalemia
  • Our Commitment to the PatientZS Pharma is committed to improving patient outcomes and care by developing novel therapies to treat and manage Hyperkalemia
1 Developing New Therapies to Improve the Treatment of Hyperkalemia2 Partnering with Clinicians to Advance Hyperkalemia Treatment 3 Our Commitment to the Patient4

Our Commitment

ZS Pharma is a biopharmaceutical company committed to the development and commercialization of highly selective, non-systemically absorbed therapeutics to treat renal, cardiovascular, liver and metabolic diseases. Our initial focus is on the development of sodium zirconium cyclosilicate (ZS-9), a highly selective inorganic cation exchanger designed to entrap excess potassium throughout the gastrointestinal tract. ZS-9 is being developed for the treatment of hyperkalemia, a potentially life-threatening condition characterized by abnormally high levels of potassium in the blood. ZS-9 has successfully completed three pivotal prospective, randomized, double-blind, placebo-controlled studies. On the basis of these studies, we plan to submit for approval of ZS-9 for the treatment of hyperkalemia with the US FDA and European Medicines Agency (EMEA) in the first half of 2015.

Stay in the Know

Keep up to date with the latest ZS Pharma News and Updates

Sign Up

 

Recent News

February 19, 2015

ZS Pharma Hires Key Medical Affairs and Commercial Executives

Download PDF

February 10, 2015

ZS Pharma Appoints Martin Babler to Board of Directors

Download PDF

January 6, 2015

ZS Pharma to Present at J.P. Morgan Healthcare Conference

Download PDF
X

Keep up to date with the latest ZS Pharma News and Updates